Which shockwave therapy devices are FDA-cleared?

What Are Shockwave Therapy Devices?

Shockwave therapy devices utilize acoustic waves to promote healing in various musculoskeletal conditions. These devices are categorized into two main types:

• Focused Shockwave Therapy (ESWT): Delivers concentrated energy to deeper tissues for precision treatment.
• Radial Shockwave Therapy (EPAT): Disperses energy over a broader, more superficial area.

The choice between these devices depends on the specific clinical indications and treatment goals. ((https://www.longestmedical.com/b2b-buyers-guide-shockwave-therapy-machine.html?utm_source=openai))

Which Shockwave Therapy Devices Are FDA-Cleared?

Several shockwave therapy devices have received FDA clearance for specific medical applications:

• SoftWave OrthoGold 100: Cleared for the treatment of superficial, partial-thickness, second-degree burns in adults and diabetic foot ulcers.

• CuraMedix DuoLith SD1 TTOP Ultra: Approved for the treatment of chronic proximal plantar fasciitis.

• Zynex TensWave: Cleared for pain management and rehabilitation through transcutaneous electrical nerve stimulation (TENS).

• InMode Evolve: An innovative hands-free platform that remodels skin, targets adipose tissue, and tones muscles.

• Storz Medical Devices: A range of radial pressure wave (EPAT) and focused shockwave (ESWT) devices, including the DUOLITH® SD1 (FSW + RSW) and MASTERPULS® ULTRA +.

What Are the Regulatory Requirements for Shockwave Therapy Devices?

To obtain FDA clearance, manufacturers must submit a 510(k) premarket notification demonstrating that their device is substantially equivalent to a legally marketed device. The submission should include:

• Device description and predicate device identification.
• Bench testing results: acoustic output, energy flux density (EFD), focal mapping, durability.
• Electrical safety and electromagnetic compatibility (EMC) reports (IEC 60601 series).
• Software documentation and testing (if applicable) per IEC 62304.
• Risk management file per ISO 14971.
• Usability engineering (IEC 62366).
• Biocompatibility testing for patient-contact materials (ISO 10993).
• Sterilization and packaging validation (if relevant).
• Labeling, instructions for use (IFU), and promotional materials draft.
• Quality system evidence (ISO 13485 or QSR compliance).
• Clinical data or literature summary supporting indications (if needed).

Engaging early with regulators and adopting international standards during design can reduce regulatory risk and speed time-to-market. ((https://www.longestmedical.com/regulatory-fda-clearance-shockwave-devices.html?utm_source=openai))

What Are the Market Considerations for Procuring Shockwave Therapy Devices?

When procuring shockwave therapy devices, consider the following:

• Device Type: Determine whether focused or radial shockwave therapy aligns with your clinical needs.
• Regulatory Status: Ensure the device has FDA clearance for the intended use.
• Clinical Evidence: Review published studies supporting the device's efficacy for specific indications.
• Cost and Return on Investment (ROI): Evaluate the device's cost relative to potential revenue generation and patient outcomes.
• Supplier Reputation: Assess the manufacturer's track record, customer support, and warranty offerings.

Conducting a thorough market analysis and consulting with industry experts can aid in making informed procurement decisions. ((https://www.longestmedical.com/b2b-buyers-guide-shockwave-therapy-machine.html?utm_source=openai))

How Does Longest Medical Support Medical Device Procurement?

Longest Medical offers comprehensive support for medical device procurement, including:

• Regulatory Guidance: Assistance with navigating FDA clearance processes and compliance with international standards.
• Product Selection: A curated portfolio of FDA-cleared shockwave therapy devices tailored to various clinical applications.
• Training and Support: Educational resources and ongoing support to ensure effective device utilization.
• Market Insights: Access to industry reports and analyses to inform procurement decisions.

Partnering with Longest Medical can streamline the procurement process and enhance clinical outcomes.

Conclusion

Selecting the appropriate FDA-cleared shockwave therapy device involves careful consideration of regulatory requirements, device specifications, clinical evidence, and market factors. Collaborating with experienced suppliers like Longest Medical can provide valuable support in making informed procurement decisions, ultimately leading to improved patient care and practice success.

References

• SoftWave Tissue Regeneration Technologies – June 1, 2021 – FDA clearance for OrthoGold 100 device.
• CuraMedix – Date not specified – FDA approval for DuoLith SD1 TTOP Ultra device.
• Zynex Medical – Date not specified – FDA clearance for TensWave device.
• InMode – Date not specified – Introduction of Evolve platform.
• Vale Medical – Date not specified – Distribution of Storz Medical devices.
• Longest Medical – Date not specified – Regulatory and market guidance for shockwave therapy devices.